Skip to main content
TipRanks
Go Ultimate75% OFF

Quoin Pharmaceuticals (QNRX) Stock Statistics & Valuation Metrics

398 Followers

Total Valuation

Quoin Pharmaceuticals has a market cap or net worth of $16.14M. The enterprise value is -$10.19M.

Market Cap
$16.14M
Enterprise Value
-$10.19M

Share Statistics

Quoin Pharmaceuticals has 4,804,161 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
4,804,161
Owned by Insiders
3.80%
Owned by Institutions
48.43%

Financial Efficiency

Quoin Pharmaceuticals’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is -109.75%.

Return on Equity (ROE)
-1.20
Return on Assets (ROA)
-0.78
Return on Invested Capital (ROIC)
-109.75%
Return on Capital Employed (ROCE)
-1.10
Revenue Per Employee
0
Profits Per Employee
-3.95M
Employee Count
4
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Quoin Pharmaceuticals is -0.36. Quoin Pharmaceuticals’s PEG ratio is -0.00.

PE Ratio
-0.36
PS Ratio
0.00
PB Ratio
0.58
Price to FCF
-0.35
Price to Operating Cash Flow
-0.87
PEG Ratio
-0.00

Income Statement

In the last 12 months, Quoin Pharmaceuticals had revenue of 0 and earned -15.80M in profits. Earnings per share was -14.80.

Revenue
0
Gross Profit
0
Operating Income
-16.29M
Pretax Income
-15.80M
Net Income
-15.80M
EBITDA
-15.70M
Earnings Per Share (EPS)
-14.80

Cash Flow

In the last 12 months, operating cash flow was -18.93M and capital expenditures 1, giving a free cash flow of -18.93M billion.

Operating Cash Flow
-18.93M
Free Cash Flow
-18.93M
Free Cash Flow per Share
-3.75

Dividends & Yields

Quoin Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-282.29%
Earnings Yield
-116.86%

Stock Price Statistics

Beta
-0.19
52-Week Price Change
-82.19%
50-Day Moving Average
4.78
200-Day Moving Average
5.68
Relative Strength Index (RSI)
32.65
Average Volume (3m)
539.84K

Important Dates

Quoin Pharmaceuticals upcoming earnings date is Mar 18, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Mar 18, 2027
Ex-Dividend Date
―

Financial Position

Quoin Pharmaceuticals as a current ratio of 3.61, with Debt / Equity ratio of 0.00%

Current Ratio
3.61
Quick Ratio
3.61
Debt to Market Cap
0.00
Net Debt to EBITDA
243.12
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Quoin Pharmaceuticals has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Quoin Pharmaceuticals EV to EBITDA ratio is 0.17, with an EV/FCF ratio of 0.18.

EV to Sales
0.00
EV to EBITDA
0.17
EV to Free Cash Flow
0.18
EV to Operating Cash Flow
0.18

Balance Sheet

Quoin Pharmaceuticals has $10.10M in cash and marketable securities with $0.00 in debt, giving a net cash position of $10.10M billion.

Cash & Marketable Securities
$10.10M
Total Debt
$0.00
Net Cash
$10.10M
Net Cash Per Share
$2.10
Tangible Book Value Per Share
$5.63

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Quoin Pharmaceuticals is $17.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$17.60
Price Target Upside
436.59% Upside
Analyst Consensus
Strong Buy
Analyst Count
5
Revenue Growth Forecast
―
EPS Growth Forecast
98.98%

Scores

Smart Score
―
AI Score
46